Advertisement
Advertisement
CLOV
Clover Health Investments, Corp
1.81
USDSponsored
-0.01
-0.27%
Mar 26, 12:23 UTC -4
Open
CLOV Earnings Reports
Positive Surprise Ratio
CLOV beat 15 of 20 last estimates.
75%
Next Report
Date of Next Report
May 04, 2026
Estimate for Q1 26 (Revenue/ EPS)
$729.19M
/$0.03
Implied change from Q4 25 (Revenue/ EPS)
+49.51%
/-130.00%
Implied change from Q1 25 (Revenue/ EPS)
+57.72%
/--
Clover Health Investments, Corp earnings per share and revenue
On Feb 26, 2026, CLOV reported earnings of -0.10 USD per share (EPS) for Q4 25, beating the estimate of -0.10 USD, resulting in a 5.12% surprise. Revenue reached 487.71 million, compared to an expected 476.40 million, with a 2.37% difference. The market reacted with a -2.79% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 5 analysts forecast an EPS of 0.03 USD, with revenue projected to reach 729.19 million USD, implying an decrease of -130.00% EPS, and increase of 49.51% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
KORU Medical Systems, Inc. Common Stock (DE)
Report Date
Mar 12, 2026 For Q4 25
Estimate
-Actual
-$0.01
Surprise
-
CareCloud, Inc. Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
$0.03
Actual
$0.03
Surprise
-15.97%
Nyxoah SA Ordinary Shares
Report Date
Mar 19, 2026 For Q4 25
Estimate
-$0.55
Actual
-$0.58
Surprise
-5.51%
Health Catalyst, Inc Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
$0.09
Actual
$0.08
Surprise
-13.79%
Neuraxis, Inc.
Report Date
Mar 19, 2026 For Q4 25
Estimate
-$0.21
Actual
-$0.17
Surprise
+22.48%
Heartflow, Inc. Common Stock
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$0.17
Actual
-$0.12
Surprise
+30.31%
Heartbeam, Inc. Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.13
Actual
-$0.14
Surprise
-0.72%
HeartSciences Inc. Common Stock
Report Date
Mar 16, 2026 For Q3 26
Estimate
-$0.86
Actual
-$0.63
Surprise
+27.34%
FAQ
What were Clover Health Investments, Corp's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Clover Health Investments, Corp reported EPS of -$0.10, beating estimates by 5.12%, and revenue of $487.71M, 2.37% above expectations.
How did the market react to Clover Health Investments, Corp's Q4 2025 earnings?
The stock price moved down -2.79%, changed from $2.15 before the earnings release to $2.09 the day after.
When is Clover Health Investments, Corp expected to report next?
The next earning report is scheduled for May 04, 2026.
What are the forecasts for Clover Health Investments, Corp's next earnings report?
Based on 5
analysts, Clover Health Investments, Corp is expected to report EPS of $0.03 and revenue of $729.19M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement